跳至主要内容
临床试验/NCT00180531
NCT00180531已完成4 期

Monitoring of Arrhythmias and Heart Rate Variability in Patients With Congestive Heart Failure Treated With the Cardiac Resynchronisation Pacemaker Renewal TR2

Guidant Corporation20 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2004年2月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
500
试验地点
20
主要终点
Occurrence of ventricular arrhythmias

研究概览

简要总结

The objective of this study is to evaluate the prevalence of sustained ventricular and supraventricular rhythm disorders in patients implanted with a CONTAK RENEWAL TR2 ventricular resynchronization therapy (CRT) device

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate or severe chronic heart failure, defined by the presence of NYHA class III or IV symptoms, Intra/interventricular synchronization disorder evaluated by echocardiography and/or Doppler Tissue Imaging (DTI, Yu's method22), Ejection fraction (EF) ≤ 40 %, If previous history of myocardial infarction, MI must be > 60 days from the date of inclusion, Estimated life expectancy > 6 months in the case of concomitant disease, Age ≥ 18 years, Optimal drug treatment of chronic heart failure (according to SFC* recommendations).

排除标准

  • Conventional indication for treatment by implantable defibrillator upon inclusion, Cardiac transplant envisaged within 6 months, Unexplained syncope, MI < 60 days before inclusion, Non compliance to drug treatment for chronic heart failure, Any coronary pathology which may be treated by revascularisation.

结局指标

主要结局

Occurrence of ventricular arrhythmias

Occurrence of supraventricular arrhythmias

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (20)

Loading locations...

相似试验